Alpha-synuclein PET scan for Parkinson's disease
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial uses a special brain scan (PET/CT) to look at a protein called alpha-synuclein in people with Parkinson's disease. The goal is to learn more about the disease and how it affects the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have suspected, newly diagnosed, or already treated Parkinson's disease.
- You are scheduled for an alpha-synuclein PET/CT scan as part of your care.
- You or your legal representative can understand the study and sign a consent form.
- You are not pregnant.
- You do not have a condition that is not Parkinson's disease (like another movement disorder).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of brain scan (PET/CT) to look at a protein called MAO-B in people with Parkinson's disease or related conditions. The scan may help doctors understand more about the disease and could be part of your regular care.
This study uses a special PET scan to look at inflammation in the brain of people with Parkinson's disease or those at risk for it. The goal is to better understand the disease and possibly find new ways to track its progression.
This research study tests a new type of brain scan (called a PET scan) that may help detect early signs of Parkinson's disease and similar conditions. You'll receive the scan and may have a spinal tap to check for specific protein markers.
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
This trial looks at brain inflammation in people with Parkinson’s using a special PET scan. The goal is to understand how brain immune activity may relate to Parkinson’s, and how the scan results change over time.
Hear when a new Alpha Synuclein Pathology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.